All Type of News
Controversy heats up over amlodipine issue
A controversy is brewing over the approval of Pfizer's amlodipine generic versions after some media's report on the Korea Food and Drug Administration's intention to permit the omission of clinical trials on latecomer...
Drug exaggerating advertising through internet to be prosecuted.
An urgent measure should be made against the exaggerating advertising over drugs, cosmetics and foods through the internet channels.
Kwangju regional KFDA announced on May 2 that they took a special inspection over...
Wholesale association asked for an assessment of Zuellig's contracts to FTC.
Korea Pharmaceutical Wholesale Association (KPWA) raised an inquiry to the Fair Trade Commission (FTC) on May 31 over whether Zuellig's contract be against "the provisions of Article of Incorporation".
KPWA pointed...
Domestic drug makers rush to develop amlodipine preparations
Korea's pharmaceutical firms are scrambling to develop the first-generic versions of Pfizer Korea's Norvasc valued at 150 billion won last year and the foreign-invested pharmaceutical firm is expected to face ...
Domestic wholesaling industry mired in business slump
Korean drug wholesalers are struggling to bottom out the protracted business recession, but sluggish OTC sales and spate of bankruptcies cast a doubt over their outlook, industry sources said recently.
The overcro...
KPA mulls strengthened DUR-related drug guidance functions
The Korea Pharmaceutical Association is considering the establishment of a DUR (drug utilization review)-related consultative body and its subcommittee in an attempt to voluntarily make the DUR road map for better dru...
Pharmacy business damaged by frequent prescription changes.
Most of retail pharmacies have faced with a mounting stock piles of unused drugs stemming from too frequent changes in physician's prescriptions as well as the wholesaler's supply avoidance of small packages, which ev...
Daewoong Pharm: 25% dividends in the stockholder's meeting.
Daewoong Pharmaceutical Co. (President: Yoon Jae-seung) decided to give 25% dividends (625 won per a common stock) in the 2nd general stockholder's meeting at the auditorium of Daewoong's office, Samsung dong Seoul, o...
Daewoong stock-holding co. elected Mr. Jung Nan-young as president.
Daewoong took the 44th general stockholder's meeting on May 28 at the auditorium of Samsung dong office, and elected Mr. Jung Nan-young as the pesident of company and Prof. Jung Ki-taek of Kyunghee Univ. Graduate Scho...
KFDA intention misinterpreted, say officials
Rejecting media reports, the Korea Food and Drug Administration said recently that it did not intend to side with latecomers, such as Daewoong and Yuhan Corp. in the controversial issue involving omission of clinical ...
